The findings suggest that age-dependent dysregulation of the Akt/mTOR and Akt/FOXO3a signaling pathways, in combination with impaired energy metabolism, underlies the observed differences in the severity and outcomes of ischemic stroke. This evidence concerns the gene AKT1 and ischemic stroke.